Replies to post #94 on Nabriva Therapeutics PLC (NBRVF)

[bUrRpPPP!]

Here's the best part.......no hiccups.....

In the NDA acceptance letter, the FDA stated that no filing or potential review issues were identified. In addition, the Agency stated that it has not referred CONTEPO to an advisory committee meeting at this time.